Woosley RL - Search Results

1

Electrophysiologic actions of high plasma concentrations of propranolol in human subjects.

Duff HJ, Roden DM, Brorson L, Wood AJ, Dawson AK, Primm RK, Oates JA, Smith RF, Woosley RL. Duff HJ, et al. Among authors: woosley rl. J Am Coll Cardiol. 1983 Dec;2(6):1134-40. doi: 10.1016/s0735-1097(83)80340-4. J Am Coll Cardiol. 1983. PMID: 6630784 Free article.

2

Spectrum of antiarrhythmic response to encainide.

Duff HJ, Roden DM, Carey EL, Wang T, Primm RK, Woosley RL. Duff HJ, et al. Among authors: woosley rl. Am J Cardiol. 1985 Nov 15;56(13):887-91. doi: 10.1016/0002-9149(85)90776-3. Am J Cardiol. 1985. PMID: 3933319

3

Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias.

Duff HJ, Roden DM, Yacobi A, Robertson D, Wang T, Maffucci RJ, Oates JA, Woosley RL. Duff HJ, et al. Among authors: woosley rl. Am J Cardiol. 1985 Feb 1;55(4):395-401. doi: 10.1016/0002-9149(85)90383-2. Am J Cardiol. 1985. PMID: 3969876 Clinical Trial.

4

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.

Roden DM, Reele SB, Higgins SB, Wilkinson GR, Smith RF, Oates JA, Woosley RL. Roden DM, et al. Among authors: woosley rl. Am J Cardiol. 1980 Sep;46(3):463-8. doi: 10.1016/0002-9149(80)90016-8. Am J Cardiol. 1980. PMID: 6158263 Clinical Trial.

5

Suppression of chronic ventricular arrhythmias with propranolol.

Woosley RL, Kornhauser D, Smith R, Reele S, Higgins SB, Nies AS, Shand DG, Oates JA. Woosley RL, et al. Circulation. 1979 Oct;60(4):819-27. doi: 10.1161/01.cir.60.4.819. Circulation. 1979. PMID: 476887

6

Disposition kinetics of encainide and metabolites.

Roden DM, Wood AJ, Wilkinson GR, Woosley RL. Roden DM, et al. Among authors: woosley rl. Am J Cardiol. 1986 Aug 29;58(5):4C-9C. doi: 10.1016/0002-9149(86)90097-4. Am J Cardiol. 1986. PMID: 3092618 Review.

7

Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.

Kopelman HA, Woosley RL, Lee JT, Roden DM, Echt DS. Kopelman HA, et al. Among authors: woosley rl. Am J Cardiol. 1988 May 1;61(13):1006-11. doi: 10.1016/0002-9149(88)90116-6. Am J Cardiol. 1988. PMID: 3284316 Clinical Trial.

8

Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs.

Woosley RL, Roden DM. Woosley RL, et al. Am J Cardiol. 1987 Apr 30;59(11):19E-25E. doi: 10.1016/0002-9149(87)90197-4. Am J Cardiol. 1987. PMID: 3554949 Review.

9

Concentration-dependent pharmacologic properties of sotalol.

Wang T, Bergstrand RH, Thompson KA, Siddoway LA, Duff HJ, Woosley RL, Roden DM. Wang T, et al. Among authors: woosley rl. Am J Cardiol. 1986 May 1;57(13):1160-5. doi: 10.1016/0002-9149(86)90692-2. Am J Cardiol. 1986. PMID: 3706170

10

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

Roden DM, Woosley RL, Primm RK. Roden DM, et al. Among authors: woosley rl. Am Heart J. 1986 Jun;111(6):1088-93. doi: 10.1016/0002-8703(86)90010-4. Am Heart J. 1986. PMID: 3716982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page